|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,75,800.00 KRW | +0.06% |
|
+1.56% | +1.98% |
| 14/07 | Celltrion Terminates, Withdraws EMA Trial Application for CT-P51 Biosimilar | MT |
| 07/07 | Celltrion Submits Amendment for Phase 3 Trial of Cancer Biosimilar to US FDA | MT |
Official Publications
No official publication found
- Stock Market
- Stocks
- A068270 Stock
- News Celltrion, Inc.
- Official Publications
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition